Literature DB >> 1003245

Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin.

P M Le Quesne, V Goldberg, F Vajda.   

Abstract

Motor nerve conduction velocity was measured after dosing guinea-pigs with 200-400 μmol/kg diphenylhydantoin (DPH) daily for three to four days. Conduction velocity fell by a mean value of 13% in animals that achieved plasma DPH levels over 200 μmol/l. There was no change in velocity with DPH levels below this value.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1003245      PMCID： PMC492503          DOI： 10.1136/jnnp.39.10.995

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  16 in total

1.  Motor nerve conduction study in patients on diphenylhydantoin therapy.

Authors:  S Chokroverty; Z A Sayeed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-12       Impact factor: 10.154

2.  Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.

Authors:  A A Eisen; J F Woods; A L Sherwin
Journal:  Neurology       Date:  1974-05       Impact factor: 9.910

3.  Nerve conduction velocity in patients on long-term diphenylhydantoin therapy.

Authors:  O Encinoza
Journal:  Epilepsia       Date:  1974-06       Impact factor: 5.864

4.  Peripheral neuropathy in long-term diphenylhydantoin therapy.

Authors:  R E Lovelace; S J Horwitz
Journal:  Arch Neurol       Date:  1968-01

5.  Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital.

Authors:  F Vajda; F M Williams; S Davidson; M A Falconer; A Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

6.  Motor nerve conduction velocity during diphenylhydantoin intoxication.

Authors:  E Birket-Smith; E Krogh
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

7.  An isothermal GLC determination of the plasma levels of carbamazepine, diphenylhydantoin, phenobarbitone and primidone.

Authors:  P A Toseland; J Grove; D J Berry
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

8.  [On the changes of conduction velocity of peripheral motor nerve fibers by dephenylhydantoin].

Authors:  H C Hopf
Journal:  Dtsch Z Nervenheilkd       Date:  1968

9.  Sensory and motor nerve conduction velocity in long-term diphenylhydantoin therapy.

Authors:  J H Xavier de Castro; M L Acosta; R E Sica; N Guercio
Journal:  Arq Neuropsiquiatr       Date:  1972-09       Impact factor: 1.420

10.  Chronic peripheral neuropathy produced by lead poisoning in guinea-pigs.

Authors:  P M Fullerton
Journal:  J Neuropathol Exp Neurol       Date:  1966-04       Impact factor: 3.685
View more
  4 in total

1.  Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates.

Authors:  S D Shorvon; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

Review 2.  Acquired pendular nystagmus.

Authors:  Sarah Kang; Aasef G Shaikh
Journal:  J Neurol Sci       Date:  2017-01-10       Impact factor: 3.181

3.  Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients.

Authors:  M Iivanainen; M Viukari; A M Seppäläinen; E P Helle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-03       Impact factor: 10.154

4.  Topiramate induced peripheral neuropathy: A case report and review of literature.

Authors:  Sherifa Ahmed Hamed
Journal:  World J Clin Cases       Date:  2017-12-16       Impact factor: 1.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.